J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Clinical Pharmacology and New Drugs, 1973; 13:28-35
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, C. R.
Right arrow Articles by Hayden, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, C. R.
Right arrow Articles by Hayden, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Respiratory Effects of Pentobarbital and Secobarbital in Clinical Doses

Colin R. Brown M.B., B.S., F.F.A.R.A.C.S.1, William H. Forrest JR. M.D.1, and Johan Hayden R.N.1

1 Departments of Anesthesia, Stanford University School of Medicine, Stanford, California; Veterans Administration Hospital, Palo Alto, California.

The respiratory depressant effects of pentobarbital and secobarbital were compared in a randomized double-blind cross-over study in human volunteers. Using a rebreathing technique, carbon dioxide response curves were plotted automatically with a special-purpose analog computer. The respiratory depressant relative potency of pentobarbital to secobarbital was found to be 1.38, with lower and upper 95 per cent confidence limits of 0.66 and 6.03. Our best estimate, based on the displacement of the respiratory response curve, is that 70 mg of secobarbital is approximately equivalent to 100 mg of pentobarbital in our population of volunteers.

Note:

We are grateful to our staff of nurse observers, programmers, technical assistants, and secretaries, and in particular to Ken James, Ph.D., Anna Marie Demeter, and John Haxo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American College of Clinical Pharmacology